Sea buckthorn has been tested against metabolic-syndrome risk factors in a meta-analysis of 15 randomized trials, and the answer splits cleanly: blood lipids improved, while blood glucose, blood pressure, and BMI did not. This page catalogs the studies behind that split. For the short version, read the metabolic page.
What metabolic syndrome means here
Metabolic syndrome is a cluster of risk factors: large waistline, high triglycerides, low HDL cholesterol, high blood pressure, and high fasting glucose. A supplement addressing the syndrome would need to move several of these. Sea buckthorn has been measured against most of them, which is what makes this catalog possible.
Geng 2022: the flagship meta-analysis
Published in Phytotherapy Research, this systematic review pooled 15 randomized controlled trials of sea buckthorn against metabolic-syndrome risk factors. The design matters: meta-analysis averages out single-trial noise, which is why the lipid result earns Moderate on the cholesterol and triglycerides pages, while the syndrome as a whole stays Preliminary.
What moved: triglycerides, total cholesterol, and LDL cholesterol went down, and HDL cholesterol went up. A subgroup analysis found the lipid drop only in participants whose blood lipids were abnormal at the start. Healthy volunteers showed no reduction in the subgroup analysis.
What did not move: blood glucose, blood pressure, and body mass index. Three clean nulls in the same analysis, and we publish them as prominently as the positives because they are what the “metabolic cure” claims quietly contradict.
Guo 2017: the independent corroboration
A separate team meta-analyzed 11 independent randomized trials on blood lipids and found that sea buckthorn improved lipid profiles. Two research groups reaching that finding is why the lipid evidence sits above the rest, with the heterogeneity caveat attached, though a 2026 meta-analysis of 12 randomized trials found no significant pooled effect on any lipid, with very low certainty (we could read only its abstract).
The supporting and the speculative
Below the meta-analyses sit smaller human studies: a low-dose berry trial in healthy adults that changed no lipid marker (Larmo 2009) and a metabolomics crossover in 80 overweight women suggesting effects differ by baseline metabolic profile (Larmo 2013). A seed-oil trial in hypertensive adults used to sit here too, until it was retracted in 2026. Below those sit animal studies on fat and glucose metabolism, hypothesis grade only. The blood sugar page and the fatty liver page show what happens when those animal findings get marketed as human results.
Why the cluster matters more than any marker
The syndrome earns its danger from combination. High triglycerides alone are a manageable problem. Add high blood pressure, high fasting glucose, and a large waistline, and the risks multiply rather than add, which is why three of five markers earns the diagnosis. This matters for reading the trial data: a supplement that improves one marker leaves the multiplication mostly intact. The interventions that move the cluster are the unglamorous ones, weight, movement, food pattern, and prescribed medication, and they move several markers at once. That is the bar a softgel cannot clear, and the frame every page in this cluster grades against.
The three tiers, sorted
- Real evidence: the lipid component. Two meta-analyses, 15 and 11 pooled trials, found improvement in triglycerides, total cholesterol, LDL, and HDL in people with abnormal baselines, and a third, from 2026, found no significant pooled effect on any lipid, all dissected in the cholesterol meta-analysis breakdown.
- Plausible: that the lipid effect, sustained for years, contributes to lower cardiovascular risk. The pathway is proven for LDL-lowering generally, unmeasured for sea buckthorn specifically.
- Marketing: “reverses metabolic syndrome,” “fixes your metabolism,” and before-and-after waistline claims. Glucose, blood pressure, and BMI were all null in the same analysis that found the lipid effect, and quoting the lipid half alone is the standard trick.
The doses and forms the trials actually used
The lipid finding pools 15 trials of sea buckthorn supplementation, so it hands you no dose to copy. Two practical consequences follow. First, a label that promises a “studied lipid dose” is promising something the pooled analysis does not define, and the study dosages page tabulates what the single trials used instead. Second, rechecking your own panel on a date you agree with your doctor is the only way to know whether the studied effect showed up in you, and the dosage page converts grams into softgels and spoons for the products people actually buy.
Common mistakes
- Reading “helps metabolic syndrome” as “helps every marker.” The data says lipids yes, the other pillars no. Both halves travel together on this site.
- Supplementing past a diagnosis. Three or more markers in the danger zone is a management relationship with your doctor, not a shopping problem.
- Skipping the recheck. Your panel, on the date you and your doctor agree, is the only verdict that counts.
How to read this catalog
If your labs show abnormal lipids, sea buckthorn is a reasonable supplement conversation with your doctor, at an amount you agree on with your doctor. If your concern is glucose, blood pressure, or BMI, the pooled answer is no proven effect, and the proven tools live with your clinician. The heart hub maps every page in this cluster, and the research hub explains how we grade each study.
Frequently asked questions
Does sea buckthorn help metabolic syndrome?
Partly, on one component. A 2022 meta-analysis of 15 randomized trials found sea buckthorn improved blood lipids, and its subgroup analysis found the drop only in people whose levels were already abnormal, but found no significant effect on blood glucose, blood pressure, or BMI. It addresses the lipid component of metabolic syndrome, not the syndrome itself, and its abstract says more clinical studies are needed to determine the real effect of sea buckthorn on metabolic syndrome.
Which form of sea buckthorn did the metabolic trials use?
The 2022 meta-analysis pooled 15 trials of sea buckthorn supplementation as one intervention and reports high heterogeneity, which is both the strength and the blur of the evidence: it shows a lipid effect on average, but not which form or dose produced it. If you and your doctor try something, agree the form and the amount with them, start at 0.5 to 1 gram a day, and stay at or below 3 grams of oil a day.
Illustration.